Viewing Study NCT00346567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-05-31 @ 7:25 AM
Study NCT ID: NCT00346567
Status: COMPLETED
Last Update Posted: 2016-02-23
First Post: 2006-06-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)
Sponsor: Rigshospitalet, Denmark
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mother-to-child-transmission View
None PMTCT View
None HIV View
None resistance View
None NNRTI View